CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
CVS Health (CVS) cuts full-year profit outlook
February 7, 2024 6:44 AM ESTCVS Health (NYSE: CVS) unveiled financial results for the fourth quarter and reduced its earnings outlook for 2024.
The stock initially fell in premarket trading before bouncing back into the green.
For FQ4 2023, the company reported earnings per share (EPS) of $2.12, topping the consensus... More
CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
February 7, 2024 6:33 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of at least $8.30, versus... More
